Loading stock data…
CLB
$13.27-0.16 (-1.19%)
After Hours$13.27+0.00 (+0.00%)· Last close Jun 9
Core Laboratories Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Core Laboratories Inc. in the Energy sector is trading at $13.27. Wall Street consensus targets $16.33 (3 analysts), implying a +23.1% move over the next 12 months. The stock is currently 35% below its 52-week high of $20.36, remaining 14.1% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +23.1% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
XOMCVXCOP
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$13.27
Potential Downside
0%
Whystock Fair Value$13.27
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segment...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.23%
ROE
Average efficiency. Growth may require heavy reinvestment.
10.80%
Volume
Today's trading volume
777,908
Recent News
Core Lab Stock Plunges 18% in 3 Months: Time to Hold or Fold?
CLB faces persistent geopolitical uncertainty, weaker laboratory activity, cost inflation and delayed shipments, limiting visibility into a stronger recovery.
TETRA Technologies and Core Laboratories Shares Skyrocket, What You Need To Know
A number of stocks jumped in the morning session after Israel and Iran launched direct strikes against each other over the weekend, the most significant test of the fragile ceasefire since April, pushing Brent crude briefly above $98 a barrel.
3 of Wall Street’s Favorite Stocks We Steer Clear Of
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Winners And Losers Of Q1: Core Laboratories (NYSE:CLB) Vs The Rest Of The Oilfield Services Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how oilfield services stocks fared in Q1, starting with Core Laboratories (NYSE:CLB).
Core Laboratories (CLB) Down 4.9% Since Last Earnings Report: Can It Rebound?
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.